October 1st was International Coffee Day, and it is estimated that half of all U.S. adults consume coffee on a daily basis. You might therefore be no stranger to taking a strong cup of coffee each time you wake up feeling groggy. But, did you know that the early morning cup of strong coffee you take could be compromising your metabolism and making it harder for your blood glucose level to be regulated? New research done at the University of Bath (UK) strongly suggests that this is the case.
The research team headed by Harry Smith performed overnight experiments on 29 men and women. In one of the experiments, the study participants were asked to sleep as they normally do at night, and then consume a sugary drink just after they woke up.
In another experiment, the study participants were woken up every hour for five minutes to simulate a disturbed night’s sleep. Upon waking up in the morning, these subjects were also given a sugary drink identical to the one of the group that didn’t have their sleep disturbed.
In a third experiment, the participants also had their sleep disrupted on an hourly basis. However, this group got a strong cup of coffee upon waking up, and then received the sugary drink half an hour later.
For each of these experiments, blood samples were drawn from the study subjects after they took the sugary drink. When these samples were analyzed, it was found that taking a strong cup of coffee before you have your breakfast can compromise your body’s ability to regulate blood glucose by at least 50%. This conclusion came after the researchers noted that the participants who took coffee 30 minutes before the sugary drink had 50% more blood glucose than what was found in the experiments in which the participants didn’t take coffee before having the sugary drink.
This surprising discovery suggests that it might be better to have your breakfast first before taking your customary cup (or cups) of coffee to perk you up in the morning.
On a more positive note, the researchers found that contrary to what was previously believed, a single night of disrupted sleep, such as when insomnia strikes or you get a new baby, isn’t sufficient to compromise your metabolism.
There is need for additional research to be done on the long-term effects of sleep disruption upon our metabolism, and to what extent exercise can counter some of those effects. While it may be hard for us ordinary mortals to adjust to such research which suggests we have been doing certain things wrong all our lives, research-heavy entities like Predictive Oncology (NASDAQ: POAI) see such groundbreaking findings as a normal part of learning.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.